Study of ASP1948, Targeting Immune Modulatory Receptor in Subjects with Advanced Solid Tumors (1948-CL-0101)
Study of ASP1948, Targeting Immune Modulatory Receptor in Subjects with Advanced Solid Tumors (1948-CL-0101)
Trial Category:
Melanoma
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
